![](/images/graphics-bg.png)
Metastatic Bladder Cancer : A Review of Current Management
Joint Authors
Fletcher, Andrew
Alam, Nooreen
Choudhury, Ananya
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-06-09
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Bladder cancer continues to result in substantial morbidity and mortality for affected individuals.
Advances in the management of metastatic bladder cancer have been limited.
Chemotherapy with platinum-based regimes remains the mainstay of first-line treatment.
Studies investigating alternative regimes have offered no survival advantage.
Targeted therapies may offer benefit either as single agent or in combination with chemotherapy.
Symptoms due to metastatic bladder cancer impact patients' quality of life, and therefore holistic management is vital.
Such management includes radiotherapy, bisphosphonates, and the involvement of specialist palliative care services.
This review will discuss the current management for metastatic bladder cancer, future potential treatment modalities, and the evidence to support the management strategies.
American Psychological Association (APA)
Fletcher, Andrew& Choudhury, Ananya& Alam, Nooreen. 2011. Metastatic Bladder Cancer : A Review of Current Management. ISRN Urology،Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-480274
Modern Language Association (MLA)
Fletcher, Andrew…[et al.]. Metastatic Bladder Cancer : A Review of Current Management. ISRN Urology No. 2011 (2011), pp.1-8.
https://search.emarefa.net/detail/BIM-480274
American Medical Association (AMA)
Fletcher, Andrew& Choudhury, Ananya& Alam, Nooreen. Metastatic Bladder Cancer : A Review of Current Management. ISRN Urology. 2011. Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-480274
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-480274